[BiO BB] New Targets and Drug Modalities
James Prudhomme
jprudhomme at healthtech.com
Wed Apr 20 12:06:14 EDT 2011
CHI and Bio-IT World's "Structure-Based Design" Conference to be
held on June 8-10, 2011 in Cambridge, MA, will feature a new session:
New Targets and Drug Modalities.
The following presentations have just been added and are scheduled
on Friday, June 10 from 1:30-3:50 p.m.
Structure-Based Ligand Discovery for GPCRs Ruben Abagyan, Ph.D.,
Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences,
University of California, San Diego
The Role of Recent Crystal Structures of Membrane Bound Proteins in
Drug Discovery for CNS Targets Sid Topiol, Ph.D., CSO, Computational
and Structural Investigations, 3D-2Drug
Hitting a Moving Target: Characterizing GPCR Signaling through Long-
timescale Molecular Dynamics Simulations Ron Dror, Ph.D., Senior
Research Scientist and Special Advisor to the Chairman, D. E. Shaw
Research
Beyond the Orthosteric Binding Site: A Structure-Based SAR Analysis of
the D3R Selective Compounds Lei Shi, Ph.D., Assistant Professor,
Department of Physiology and Biophysics, HRH Prince Alwaleed Bin
Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine,
Weill Cornell Medical College
Moving in New Circles - Exploiting Macrocycles for Drug Discovery Nick
Terrett, Ph.D., CSO, Ensemble Therapeutics Corp
View full details and register at: http://www.healthtech.com/sbd or call
781-972-5400.
Those that register by April 29 will receive the advanced registration
discount.
- James Prudhomme
James Prudhomme
Marketing Manager
Cambridge Healthtech Institute
Tel: 781-972-5486
jprudhomme at healthtech.com
More information about the BBB
mailing list